418 related articles for article (PubMed ID: 21537818)
41. Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - a prospective study.
Schmitt J; Heese E; Wozel G; Meurer M
Dermatology; 2007; 214(1):68-76. PubMed ID: 17191051
[TBL] [Abstract][Full Text] [Related]
42. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
[TBL] [Abstract][Full Text] [Related]
43. Quality of life and sexual health in patients with genital psoriasis.
Meeuwis KA; de Hullu JA; van de Nieuwenhof HP; Evers AW; Massuger LF; van de Kerkhof PC; van Rossum MM
Br J Dermatol; 2011 Jun; 164(6):1247-55. PubMed ID: 21332459
[TBL] [Abstract][Full Text] [Related]
44. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
Fortune DG; Main CJ; O'Sullivan TM; Griffiths CE
Br J Dermatol; 1997 Nov; 137(5):755-60. PubMed ID: 9415236
[TBL] [Abstract][Full Text] [Related]
45. The effect of treatment on quality of life in psoriasis patients.
Prins M; Krabbe PF; Swinkels QO; de Boo T; van de Kerkhof PC; van der Valk PG
Acta Derm Venereol; 2005; 85(4):304-10. PubMed ID: 16191850
[TBL] [Abstract][Full Text] [Related]
46. Psychosocial stress affects the change of mental distress under dermatological treatment-A prospective cohort study in patients with psoriasis.
Wintermann GB; Bierling AL; Peters EMJ; Abraham S; Beissert S; Weidner K
Stress Health; 2024 Feb; 40(1):e3263. PubMed ID: 37243509
[TBL] [Abstract][Full Text] [Related]
47. Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.
Daudén E; Griffiths CE; Ortonne JP; Kragballe K; Molta CT; Robertson D; Pedersen R; Estojak J; Boggs R
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1374-82. PubMed ID: 19563497
[TBL] [Abstract][Full Text] [Related]
48. The role of tar in Goeckerman therapy.
Belsito DV; Kechijian P
Arch Dermatol; 1982 May; 118(5):319-21. PubMed ID: 7082024
[TBL] [Abstract][Full Text] [Related]
49. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
[TBL] [Abstract][Full Text] [Related]
50. Tomesa balneophototherapy in mild to severe psoriasis: a retrospective clinical trial in 174 patients.
Cattaneo A; Violetti SA; Tavecchio S; Bruni E; Carrera C; Crosti C
Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):169-71. PubMed ID: 22548402
[TBL] [Abstract][Full Text] [Related]
51. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients.
Sears SF; Sowell LD; Kuhl EA; Kovacs AH; Serber ER; Handberg E; Kneipp SM; Zineh I; Conti JB
Pacing Clin Electrophysiol; 2007 Jul; 30(7):858-64. PubMed ID: 17584267
[TBL] [Abstract][Full Text] [Related]
52. A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis.
Brockow T; Schiener R; Franke A; Resch KL; Peter RU
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1027-37. PubMed ID: 17714121
[TBL] [Abstract][Full Text] [Related]
53. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
Tiplica GS; Salavastru CM
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
[TBL] [Abstract][Full Text] [Related]
54. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
55. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
[TBL] [Abstract][Full Text] [Related]
56. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
57. Perceived stress, stress attributions and psychological distress in psoriasis.
O'Leary CJ; Creamer D; Higgins E; Weinman J
J Psychosom Res; 2004 Nov; 57(5):465-71. PubMed ID: 15581650
[TBL] [Abstract][Full Text] [Related]
58. Influence of dermal exposure to ultraviolet radiation and coal tar (polycyclic aromatic hydrocarbons) on the skin aging process.
Borska L; Andrys C; Krejsek J; Palicka V; Vorisek V; Hamakova K; Kremlacek J; Borsky P; Fiala Z
J Dermatol Sci; 2016 Mar; 81(3):192-202. PubMed ID: 26748978
[TBL] [Abstract][Full Text] [Related]
59. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: lessons from the Salies de Béarn randomized study.
Léauté-Labrèze C; Saillour F; Chêne G; Cazenave C; Luxey-Bellocq ML; Sanciaume C; Toussaint JF; Taïeb A
Arch Dermatol; 2001 Aug; 137(8):1035-9. PubMed ID: 11493096
[TBL] [Abstract][Full Text] [Related]
60. A novel, web-based, psychological intervention for people with psoriasis: the electronic Targeted Intervention for Psoriasis (eTIPs) study.
Bundy C; Pinder B; Bucci S; Reeves D; Griffiths CE; Tarrier N
Br J Dermatol; 2013 Aug; 169(2):329-36. PubMed ID: 23551271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
